Medical Letter on the CDC & FDA
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC & FDA
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunotherapy
Findings from Naval Medical Center provide new insights into immunotherapy
November 9th, 2008
New investigation results, 'Perception and practice of sublingual immunotherapy among practicing allergists,' are detailed in a study published in Annals of Allergy, Asthma & Immunology. According to recent research published in the journal Annals of Allergy, Asthma & Immunology, "Currently, little information is available regarding who is using sublingual immunotherapy (SLIT) in the United States, what product they may be using, how they are dosing that product, and what perceived effect it may be having on patients. To gather information regarding the perception and use of SLIT among practicing allergists in the United States." "On behalf of the American...
Source: Medical Letter on the CDC & FDA (2008-11-09)
|
